The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis
- 1 May 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 30 (4) , 323-335
- https://doi.org/10.1016/0049-3848(83)90224-4
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- Failure of aspirin at different doses to modify experimental thrombosis in ratsThrombosis Research, 1980
- A randomized, controlled trial of aspirin in persons recovered from myocardial infarctionPublished by American Medical Association (AMA) ,1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976
- Effect of anticoagulants and inhibitors of platelet aggregation on thrombotic occlusion of endarterectomized cat carotid arteries.Stroke, 1976
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975